Project Raising Exposure Awareness for Caregiver Help-Seeking (Project REACH)
A Direct-to-consumer Dissemination Campaign About Exposure to Increase Treatment Access
The goal of this pilot randomized study is to learn whether a dissemination campaign co-designed with a community advisory board helps caregivers of children with anxiety and related disorders seek exposure therapy, compared with standard information. Participants are caregivers of children ages 4 to 18 with current anxiety, OCD, or traumatic stress symptoms.
The main questions it aims to answer are:
Does the dissemination campaign improve caregivers' knowledge of exposure therapy, attitudes toward it, perceived norms about seeking it, and confidence that they can find an exposure therapist, compared with dissemination-as-usual?
Does the dissemination campaign increase caregivers' intentions to seek exposure therapy for their child, compared with dissemination-as-usual?
Researchers will compare the dissemination campaign to dissemination-as-usual, which is links to professional organization websites and advice to contact their insurance company or search an online therapist directory.
Participants will:
- Complete an online survey about their help-seeking intentions, knowledge, attitudes, norms, and confidence
- Be randomly assigned to review either the dissemination campaign or dissemination-as-usual materials for at least 10 minutes
- Complete the same survey again right after reviewing the materials
- Possibly be invited to a 15-minute phone interview 2 months later about whether they sought treatment for their child and what barriers they faced
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Intervention / Traitement
Intervention / Traitement
Type d'étude
Type d'étude
Inscription (Estimé)
Inscription
Phase
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
Coordonnées de l'étude
- Nom: Hannah E Frank, PhD
- Numéro de téléphone: 401-444-1941
- E-mail: hannah_frank@brown.edu
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
Adult (age 18 or older) parent or other family caregiver Has a child aged 4 to 18 years with current symptoms of anxiety, obsessive-compulsive disorder (OCD), and/or traumatic stress, by caregiver report Able to read and understand English Able to provide informed consent
Exclusion Criteria:
Survey responses flagged as likely invalid or inaccurate during data screening, including uniform responding or duplicate or suspicious IP addresses Previous participation in this study
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Nombre de bras
Armes et Interventions
Groupe de participants / BrasGroupe de participants / Bras |
Intervention / TraitementIntervention / Traitement |
|---|---|
|
Expérimental: Tailored Dissemination Campaign
Caregivers are randomized to review the community advisory board-designed dissemination campaign, including flyers, infographics, testimonial videos, and explainer video. |
A direct-to-consumer dissemination campaign about exposure therapy for youth anxiety and related disorders, co-designed with a community advisory board of family caregivers and providers and refined through caregiver focus groups. It covers the same core content as standard information about finding mental health care, but uses terminology and explanations developed with the advisory board. It also includes a skills-focused "how-to" guide for finding and accessing an exposure therapist. The campaign targets help-seeking mechanisms from the Theory of Planned Behavior: knowledge, attitudes, perceived norms, and self-efficacy. Participants review the materials online for at least 10 minutes. |
|
Comparateur actif: Dissemination-as-usual
Caregivers are randomized to review standard information about finding mental health services for their child (e.g., information found via google and foundation websites) |
Standard information about seeking mental health care for a child: links to professional organization websites and summary of information generated from Google searches. Participants review the materials online for at least 10 minutes. |
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Caregiver Self-Efficacy for Seeking Exposure Therapy
Délai: Baseline (pre-review) and immediately post-review (same study session)
|
Self-efficacy for finding an exposure therapist for one's child, measured with two caregiver-report items rated on a 7-point agreement scale (e.g., "If I really wanted to, I could find an exposure specialist for my child"). The items are averaged into a score from 1 to 7, and higher scores indicate greater self-efficacy. Groups will be compared on the post-review score, controlling for baseline. |
Baseline (pre-review) and immediately post-review (same study session)
|
|
Caregiver Attitudes Toward Exposure Therapy
Délai: Baseline (pre-review) and immediately post-review (same study session)
|
Attitudes toward exposure therapy, measured with four standard semantic differential scales. The total score is the average of z-standardized items, and higher scores indicate more favorable attitudes. Groups will be compared on the post-review score, controlling for baseline. |
Baseline (pre-review) and immediately post-review (same study session)
|
|
Perceived Norms for Seeking Exposure Therapy
Délai: Baseline (pre-review) and immediately post-review (same study session)
|
Perceived norms about seeking exposure therapy, measured with two items rated on a 7-point agreement scale. One asks whether "other caregivers like me" would seek exposure therapy, and the other asks whether people important to the caregiver would approve. The items are averaged into a score from 1 to 7, and higher scores indicate more favorable perceived norms. Groups will be compared on the post-review score, controlling for baseline. |
Baseline (pre-review) and immediately post-review (same study session)
|
Mesures de résultats secondaires
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Caregiver Intentions to Seek Exposure Therapy
Délai: Baseline (pre-review) and immediately post-review (same study session)
|
Strength of caregivers' intentions to seek exposure therapy for their child, measured with two items rated on a 7-point scale: how willing and how likely the caregiver is to seek exposure therapy. The items are averaged into a score from 1 to 7, and higher scores indicate stronger intentions. Groups will be compared on the post-review score, controlling for baseline. |
Baseline (pre-review) and immediately post-review (same study session)
|
|
Caregiver Knowledge of Exposure Therapy
Délai: Baseline (pre-review) and immediately post-review (same study session)
|
Caregiver awareness of and prior experience with exposure therapy, measured with a previously developed two-item measure. Groups will be compared on the post-review score, controlling for baseline. |
Baseline (pre-review) and immediately post-review (same study session)
|
|
Acceptability of Dissemination Strategies
Délai: Immediately post-review (same study session)
|
Caregiver ratings of the acceptability of each dissemination strategy developed with the community advisory board. |
Immediately post-review (same study session)
|
|
Caregiver-Reported Connection to Mental Health Services
Délai: 2 months post-review
|
Number of caregivers in a purposive subsample (n=32; 16 per arm, selected for high or low baseline intentions) who report successfully connecting their child with mental health services, and the type of treatment sought (including exposure therapy). This is assessed in a 15-minute structured phone interview. Reported barriers to accessing care and the influence of study materials on help-seeking will be analyzed qualitatively with rapid qualitative analysis, using codes from the Theory of Planned Behavior. |
2 months post-review
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Collaborateurs
Collaborateurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Début de l'étude
Achèvement primaire (Estimé)
Achèvement primaire
Achèvement de l'étude (Estimé)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- STUDY00000708
- U54GM115677 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
De-identified individual participant data from the quantitative surveys will be shared, including baseline and post-review measures of help-seeking intentions, knowledge, attitudes, perceived norms, self-efficacy, and acceptability, along with de-identified demographic and child symptom data. Qualitative interview transcripts will not be shared, to protect participant confidentiality.
Délai de partage IPD
Data will be available beginning 6 months after publication of the primary results and for at least 3 years after that.
Critères d'accès au partage IPD
Data will be available to qualified researchers who submit a methodologically sound proposal to the study PI and sign a data use agreement
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
- CIF
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .